Information card for entry 2231086
Chemical name |
4-(4-{[(2-Phenylquinazolin-4-yl)oxy]methyl}-1<i>H</i>-1,2,3-triazol- 1-yl)butan-1-ol hemihydrate |
Formula |
C21 H22 N5 O2.5 |
Calculated formula |
C21 H22 N5 O2.5 |
Title of publication |
4-(4-{[(2-Phenylquinazolin-4-yl)oxy]methyl}-1<i>H</i>-1,2,3-triazol-1-yl)butan-1-ol hemihydrate |
Authors of publication |
Ouahrouch, Abdelaaziz; Lazrek, Hassan B.; Taourirte, Moha; El Azhari, Mohamed; Saadi, Mohamed; El Ammari, Lahcen |
Journal of publication |
Acta Crystallographica Section E |
Year of publication |
2011 |
Journal volume |
67 |
Journal issue |
8 |
Pages of publication |
o2029 - o2030 |
a |
11.359 ± 0.004 Å |
b |
7.694 ± 0.003 Å |
c |
22.817 ± 0.007 Å |
α |
90° |
β |
101.111 ± 0.016° |
γ |
90° |
Cell volume |
1956.7 ± 1.2 Å3 |
Cell temperature |
296 ± 2 K |
Ambient diffraction temperature |
296 ± 2 K |
Number of distinct elements |
4 |
Space group number |
14 |
Hermann-Mauguin space group symbol |
P 1 21/n 1 |
Hall space group symbol |
-P 2yn |
Residual factor for all reflections |
0.0558 |
Residual factor for significantly intense reflections |
0.0415 |
Weighted residual factors for significantly intense reflections |
0.1161 |
Weighted residual factors for all reflections included in the refinement |
0.1273 |
Goodness-of-fit parameter for all reflections included in the refinement |
1.028 |
Diffraction radiation wavelength |
0.71073 Å |
Diffraction radiation type |
MoKα |
Has coordinates |
Yes |
Has disorder |
No |
Has Fobs |
Yes |
For the version history of this entry, please navigate to main COD server.
The link is:
https://www.crystallography.net/2231086.html